Read Now
Real-World DermaSensor Results in Primary Care
See real-world DermaSensor results from a primary care practice, including skin cancer diagnoses, diagnostic yield, referrals, and device use.
Skin Cancer Insights
Discover our latest resources like blog posts, webinars, white papers, case studies and solution briefs, with insightful information on the AI-powered device that detects skin cancer.
Read Now
See real-world DermaSensor results from a primary care practice, including skin cancer diagnoses, diagnostic yield, referrals, and device use.
Read Now
Can AI replace a dermatologist? No, and that is not the role of AI in skin cancer care. AI can support physicians with objective information when assessing suspicious skin lesions, while clinical judgment and dermatology expertise stay at the center of care.

Skin cancers are often first seen in primary care. Learn why they get missed, what the evidence shows, and how PCPs can close the gap with DermaSensor.

Guidance and information to support the preparation of documentation for government and private insurance plans to support coverage and payment.


The U.S. Food and Drug Administration’s (FDA) recent authorization of DermaSensor, an AI-enabled device for skin cancer detection in primary care, marks a pivotal moment in digital health innovation. Clinically, the authorization of the first AI-enabled device for use by non-specialists for detecting skin cancer reinforces the feasibility of digital health technologies to bridge gaps […]